Symptomatic therapy in multiple sclerosis: Big pharma should do more - YES

Aksel Siva; Orhun Kantarci

doi:10.1177/1352458515588974

Symptomatic therapy in multiple sclerosis: Big pharma should do more - YES

Neurology

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	980-982
Number of pages	3
Journal	Multiple Sclerosis
Volume	21
Issue number	8
DOIs	https://doi.org/10.1177/1352458515588974
State	Published - Jul 11 2015

ASJC Scopus subject areas

Neurology
Clinical Neurology

Access to Document

10.1177/1352458515588974

Cite this

@article{8927360e525647c8b50f762a789e7e66,

title = "Symptomatic therapy in multiple sclerosis: Big pharma should do more - YES",

author = "Aksel Siva and Orhun Kantarci",

year = "2015",

month = jul,

day = "11",

doi = "10.1177/1352458515588974",

language = "English (US)",

volume = "21",

pages = "980--982",

journal = "Multiple Sclerosis",

issn = "1352-4585",

publisher = "SAGE Publications Ltd",

number = "8",

}

TY - JOUR

T1 - Symptomatic therapy in multiple sclerosis

T2 - Big pharma should do more - YES

AU - Siva, Aksel

AU - Kantarci, Orhun

PY - 2015/7/11

Y1 - 2015/7/11

UR - http://www.scopus.com/inward/record.url?scp=84985995993&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84985995993&partnerID=8YFLogxK

U2 - 10.1177/1352458515588974

DO - 10.1177/1352458515588974

M3 - Article

C2 - 26084347

AN - SCOPUS:84985995993

SN - 1352-4585

VL - 21

SP - 980

EP - 982

JO - Multiple Sclerosis

JF - Multiple Sclerosis

IS - 8

ER -

Symptomatic therapy in multiple sclerosis: Big pharma should do more - YES

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this